Showing results (21-30 of 349) with videos related to
Sort By:
Pageof 35
Current Treatment Options in Oncology|February 8, 2014
Potential of new therapies like anti-PD1 in kidney cancerAnasuya Gunturi, David F McDermottExpert Opinion on Biological Therapy|August 21, 2018
Ipilimumab in combination with nivolumab for the treatment of renal cell carcinomaXin Gao, David F McDermottLife (Basel, Switzerland)|January 21, 2022
Immunotherapy and Metastatic Renal Cell Carcinoma: A Review of New Treatment ApproachesNikhita Kathuria-Prakash, Claire Drolen, Christopher A Hannigan, et al.Hematology/Oncology Clinics of North America|July 19, 2011
Immunotherapy for renal cell carcinomaJacalyn Rosenblatt, David F McDermottInternational Journal of Oncology|January 17, 2009
Epigenetic regulation of hTERT promoter in hepatocellular carcinomasDimitrios Iliopoulos, Maria Satra, Alexandra Drakaki, et al.Case Reports in Oncological Medicine|April 26, 2019
Treating Penile Cancer in the Immunotherapy and Targeted Therapy EraGavin Hui, Sanaz N Ghafouri, John Shen, et al.International Journal of Molecular Sciences|September 14, 2024
MicroRNAs in Genitourinary Malignancies: An Exciting Frontier of Cancer Diagnostics and TherapeuticsNikhita Kathuria-Prakash, Pranali Dave, Lizette Garcia, et al.Trends in Immunology|February 28, 2026
Cytokine specificity in macrophages: JAK-STAT and beyondJosje M A Huisman, Alexandra Drakaki, Thomas Decker, et al.Cancer Treatment Reviews|February 2, 2010
Bevacizumab as a treatment option in advanced renal cell carcinoma: an analysis and interpretation of clinical trial dataDavid F McDermott, Daniel J GeorgeCancer Medicine|January 10, 2014
PD-1 as a potential target in cancer therapyDavid F McDermott, Michael B AtkinsPageof 35